Page last updated: 2024-08-22

doxifluridine and Cancer of Esophagus

doxifluridine has been researched along with Cancer of Esophagus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bacsó, Z; Eliason, JF; Megyeri, A; Shields, A1
Hoshino, K; Ikeda, H; Kamoshita, N; Kobayashi, J; Koyama, T; Morishita, Y; Nakamura, M; Tanaka, T1
Fujimura, N; Ishida, C; Koyama, S; Maezato, K; Makino, N; Matsukawa, Y; Matsumoto, K; Mizuno, Y; Naitoh, M; Yamamoto, E1

Other Studies

3 other study(ies) available for doxifluridine and Cancer of Esophagus

ArticleYear
Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry.
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2005, Volume: 64, Issue:2

    Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Dihydrouracil Dehydrogenase (NADP); Esophageal Neoplasms; Floxuridine; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Laser Scanning Cytometry; Neoplasms; Pyrimidines; Thymidine Phosphorylase

2005
[Unresectable gastric cancer followed by remarkably effective tumor disappearance and good quality of life for 10 months after CDDP/5'-DFUR combination chemotherapy--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Esophageal Neoplasms; Female; Floxuridine; Humans; Infusions, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Quality of Life; Stomach Neoplasms

1996
[A case of recurrent esophageal cancer maintaining complete long-term response after 5'-DFUR and ftorafur administrations].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:4

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Floxuridine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Tegafur

1992